Latham Biopharm Group (LBG), is a Consulting company focused on Life Sciences. We provide Product Development Services from pre-IND animal tox study development, through CMC and clinical development of therapeutics, vaccines, cell/gene therapy, and small molecules. Our team of 20 consultants are subject-matter-experts in all core technical, quality, regulatory, knowledge management and project management aspects of taking products through the clinical development process.
In addition, LBG has extensive expertise in winning and managing US Government non-dilutive funding sources and managing complex, long term programs. Benchmarking industry data, development of COGs and cost-of-ownership modeling and strategic analysis is also a core expertise at LBG

Contact Latham Biopharm Group
Visit Website